Text Size

Education Program for Patients Receiving Oral Anticoagulation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by University of Sao Paulo.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Information provided by:
University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT01339611
First received: April 13, 2011
Last updated: June 17, 2011
Last verified: March 2010
History of Changes
  Purpose

The aim of the study is to test if patients under oral anticoagulation therapy who are going to participate in the education program will have better Health-related quality of life, higher rate in pharmacological treatment adherence and better self efficacy to manage the treatment.


Condition Intervention
Cardiovascular Disease
Venous Thromboses
Atrial Fibrillation
Blood Coagulation Disorders, Inherited
 Behavioral: Educational program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Sao Paulo:

Primary Outcome Measures:
  • Change from Baseline in health-related quality of life at 2 months [ Time Frame: baseline (hospitalization time) and two months after discahrge ] [ Designated as safety issue: Yes ]
    the health-related quality of life will be measure by Duke Anticoagulation Satisfaction Scale


Secondary Outcome Measures:
  • change from baseline in oral anticoagulation treatment adherence at 2 months [ Time Frame: baseline (hospitalization time) and two months after discahrge ] [ Designated as safety issue: Yes ]
    Treatment adhrence will be measure by on specif scale


Estimated Enrollment: 160
Study Start Date: May 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Educational Program
Patients who are going to use of oral anticoagulant will participate in an individual orientation, using instructional material (slides and illustrative booklet) during hospitalization period and the telephone follow-up at a week and four weeks after discharge
 Behavioral: Educational program
Individual orientation (slides) during hospitalization period and telephone follow-up after discharge
usual care
Patients who are going to use of oral anticoagulant will have usual orientation from the health service (illustrative booklet) during hospitalization time. No telephone follow-up after discharge.
 Behavioral: Educational program
Individual orientation (slides) during hospitalization period and telephone follow-up after discharge

Detailed Description:

Patients who are going to use oral anticoagulant will participate in an individual orientation, using instructional material (slides and illustrative booklet) during hospitalization period. After the discharge 2 phone calls will be done (after: a week and four weeks) focusing on the strategies to improve patient's self-efficacy to manage the oral anticoagulation. There will be a personal contact among researcher and participants when the patients return at the oral anticoagulant ambulatory, two months after the treatment start. At this time the following variables of interest will be evaluated: Health-related quality of life; adherence to treatment and patients' self-efficacy.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients admitted in two public hospitals, in São Paulo state interior and who are going to start the use of oral anticoagulant during this hospitalization
  • Patients admitted in two public hospitals, in São Paulo state interior and who are going to adjust therapeutically oral anticoagulant dosage or to start over treatment.

Exclusion Criteria:

  • Individuals who do not at all have any ability to understand the data collection instrument questions, measured by the instrument Mental State Mini-exam.
  • Individuals who do not have a telephone to be contacted after hospital discharge;
  • Individuals who are going to metallic valve prosthesis implant surgery in the last six months.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01339611

Contacts
Contact: Flávia M Pelegrino, MNS, PhD candidate 55-16-36023402 flavia-martinelli@bol.com.br
Contact: Inaiara A Scalçone, MNS, PhD candidate 55-16-36023402 inaenf@yahoo.com.br

Locations
Brazil
Hospital Estadual de Ribeirão Preto Recruiting
Ribeirão Preto, São Paulo, Brazil, 14090140
Contact: Flavia M Pelegrino, RN     16 36023402     flavia-martineli@bol.com.br    
Contact: Inaiara S Corbi, RN     16 36023402     inaenf@yahoo.com    
Principal Investigator: Rosana S Dantas, PhD            
Sponsors and Collaborators
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo
Investigators
Principal Investigator: Flávia M Pelegrino, MNS, PhD candidate University of São Paulo at Ribeirão Preto College of Nursing
Principal Investigator: Inaiara S.A. Corbi, MNS, PhD candidate University of São Paulo at Ribeirão Preto College of Nursing
Study Director: Rosana A.S. Dantas, PhD University of São Paulo at Ribeirão Preto College of Nursing
  More Information

No publications provided

Responsible Party: Rosana Aparecida Spadoti Dantas, University of Sao Paulo
ClinicalTrials.gov Identifier: NCT01339611     History of Changes
Other Study ID Numbers: OATeducation
Study First Received: April 13, 2011
Last Updated: June 17, 2011
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by University of Sao Paulo:
quality of life
medical adherence
warfarin
Health education

Additional relevant MeSH terms:
Atrial Fibrillation
Blood Coagulation Disorders
Hemostatic Disorders
Cardiovascular Diseases
Thrombosis
Venous Thrombosis
Venous Thromboembolism
Blood Coagulation Disorders, Inherited
Arrhythmias, Cardiac
 Heart Diseases
Pathologic Processes
Hematologic Diseases
Vascular Diseases
Hemorrhagic Disorders
Embolism and Thrombosis
Thromboembolism
Genetic Diseases, Inborn

ClinicalTrials.gov processed this record on May 19, 2013